 |
|
Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids
Hanbyeol Lee, Jeong Suk Im, Da Bin Choi, Dong-Hun Woo
Organoid. 2021;1:e11 Published online 2021 Jul 15 DOI: https://doi.org/10.51335/organoid.2021.1.e11
|
|
Citations to this article as recorded by
 Bridging the organoid translational gap: integrating standardization and micropatterning for drug screening in clinical and pharmaceutical medicine
Haowei Yang, Jiawei Li, Zitian Wang, Davit Khutsishvili, Jiyuan Tang, Yu Zhu, Yongde Cai, Xiaoyong Dai, Shaohua Ma
Life Medicine.2024;[Epub] CrossRef The ethical landscape of human brain organoids and a mindful innovation framework
Nathan A. Shlobin, Julian Savulescu, Matthew L. Baum
Nature Reviews Bioengineering.2024; 2(9): 785. CrossRef Rethinking the Three Rs: Growing Momentum Toward a New Gold Standard in Australian Research
Natalie Anderson, Rachel Smith
Alternatives to Laboratory Animals.2024; 52(4): 224. CrossRef Organoid Global Regulatory Policy: A Cross-Sectional Study
SuA Oh, EunYoung Kim
Drug Targets and Therapeutics.2024; 3(2): 169. CrossRef A tumour-spheroid manufacturing and cryopreservation process that yields a highly reproducible product ready for direct use in drug screening assays
Md. Shafiullah Shajib, Kathryn Futrega, Anthony M. Davies, Rose Ann G. Franco, Eamonn McKenna, Bianca Guillesser, Travis J. Klein, Ross W. Crawford, Michael R. Doran
Journal of The Royal Society Interface.2023;[Epub] CrossRef
|